Malaria caused by Plasmodium falciparum remains the leading single-agent cause of mortality in children, yet the promise of an effective vaccine has not been fulfilled. Here …
DK Raj, C Nixon, S Pond-Torl, J Kurtis - International Journal of …, 2016 - ijidonline.com
Background: Malaria affects almost one-half of the world's population and causes more than 600,000 deaths annually. Young children in malaria endemic areas of Africa have the …
KH Wrighton - Nat Rev Drug Discov, 2020 - nature.com
Developing a vaccine to prevent malaria caused by the parasite Plasmodium falciparum has proved highly challenging. Raj et al. now show that P. falciparum glutamic acid-rich protein …
AD Mohapatra, J Zuromski, J Kurtis - Malaria Immunology: Targeting the …, 2022 - Springer
Apoptosis is conventionally regarded as an evolutionarily conserved and genetically controlled process of programmed cell death confined to metazoan organisms. However …
Results: Published text:“Four of the five monoclonal antibodies (CIS23, CIS34, CIS42 and CIS43) showed dose-dependent binding to rPfCSP and PfSPZ in an ELISA and had …
Novel vaccines are urgently needed to reduce the burden of severe malaria. Using a differential whole-proteome screening method, we identified Plasmodium falciparum …
PC Bull, BS Lowe, M Kortok, CS Molyneux… - Nature medicine, 1998 - nature.com
The feasibility of a malaria vaccine is supported by the fact that children in endemic areas develop naturally acquired immunity to disease. Development of disease immunity is …
CJ Schwake, RM Krueger, T Hanada… - The Journal of …, 2024 - academic.oup.com
Plasmodium falciparum glutamic acid-rich protein (PfGARP) is a recently characterized cell surface antigen encoded by Plasmodium falciparum, the causative agent of severe human …
C Hon, K Matuschewski - Trends in parasitology, 2020 - cell.com
Naturally acquired anti-Plasmodium falciparum immunity protects first and foremost against severe disease. Raj et al. have established a tantalizing path towards an anti-disease …